Poster #212 RISK OF RELAPSE AND HOSPITALIZATION IN THE 2-YEAR OPEN-LABEL TREATMENT OF OUTPATIENTS WITH SCHIZOPHRENIA RANDOMIZED TO OLANZAPINE LONG-ACTING INJECTION OR ORAL OLANZAPINE

✍ Scribed by Novick, Diego; Ascher-Svanum, Haya; Bertsch, Jordan; Detke, Holland C.; McDonnell, David; Haro, Josep Maria

• Book ID: 123121802
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 69 KB
• Volume: 136
• Category: Article
• ISSN: 0920-9964
• DOI: 10.1016/S0920-9964(12)71044-7